Zhi Jian Chen
Directeur/Membre du Conseil chez Shanghai Haihe Biopharma Co., Ltd.
Postes actifs de Zhi Jian Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
Shanghai Haihe Biopharma Co., Ltd.
 Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Directeur/Membre du Conseil | 01/01/2018 | - |
Huatai Futures Co., Ltd.
 Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Directeur/Membre du Conseil | 28/12/2010 | - |
Historique de carrière de Zhi Jian Chen
Anciens postes connus de Zhi Jian Chen
| Sociétés | Poste | Début | Fin |
|---|---|---|---|
| DELUXE FAMILY CO., LTD. | Directeur/Membre du Conseil | 23/08/2010 | 31/05/2012 |
| Conseiller Juridique Général | 23/08/2010 | 31/05/2012 | |
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Directeur/Membre du Conseil | 06/01/2012 | 06/01/2012 |
Statistiques
Internationale
| Chine | 5 |
Opérationnelle
| Director/Board Member | 4 |
| General Counsel | 1 |
Sectorielle
| Finance | 4 |
| Commercial Services | 2 |
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| DELUXE FAMILY CO., LTD. | Finance |
| Entreprise privées | 3 |
|---|---|
| Shanghai Nanjiang Group Co. Ltd. /Old/ | Finance |
Shanghai Haihe Biopharma Co., Ltd.
Shanghai Haihe Biopharma Co., Ltd. Miscellaneous Commercial ServicesCommercial Services Shanghai Haihe Biopharma Co., Ltd engages in the development, production, and sale of anti-tumor innovative drugs. It focuses on new anti-tumor drug projects, providing cancer therapies, and development of anti-tumor drugs such as oral paclitaxel, tyrosine kinase inhibitors, PI3Ka inhibitors, and Glumetinib. The company was founded on March 11, 2011 and is headquartered in Shanghai, China. | Commercial Services |
Huatai Futures Co., Ltd.
Huatai Futures Co., Ltd. Investment ManagersFinance Part of Huatai Securities Co., Ltd., Huatai Futures Co., Ltd. provides investment brokerage and asset management services. The company is based in Guangzhou, China. The Chinese company was founded in 1994. The CEO is Chang Tao Zhao. | Finance |
- Bourse
- Insiders
- Zhi Jian Chen
- Expérience
